LEIGH LUNA: Open Payments
NPI 1144677824 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$63,912 in 99 payments from 18 companies in 2025. Trend: 2023 $1,287 · 2024 $2,336 · 2025 $63,912
Speaker / faculty: $52,877Consulting: $6,750Food & beverage: $2,875Travel & lodging: $1,410
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 55 | $61,953 |
| Otsuka America Pharmaceutical, Inc. | 16 | $342 |
| Gilead Sciences, Inc. | 2 | $233 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $199 |
| UCB, Inc. | 7 | $175 |
| ABBVIE INC. | 1 | $118 |
| ANI Pharmaceuticals, Inc. | 1 | $113 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $100 |
| Amgen Inc. | 1 | $99 |
| Radius Health, Inc. | 1 | $91 |
Products named: INGREZZA, REXULTI, XIFAXAN, QULIPTA, Yeztugo, PURIFIED CORTROPHIN GEL, EVENITY, Tymlos.
Industry payments across AL — which companies pay providers there.
